T h e elucidation of the mechanisms by which growth factors regulate cellular mitogenesis has emerged as one of the fundamental problems in biology and may prove crucial for understanding the unrestrained proliferation o f cancer cclls. In this respect. cultured fibroblasts. such a s murine 3T3 cells, have emerged as a model system. These cclls cease t o proliferate when they deplete the medium of its growth promoting activity and enter a quiescent o r non-dividing state. However, such cells remain viable and can be stimulated to reinitiate DNA synthesis and cell division either by replenishing the medium with fresh serum, or by the addition of purified growth factors o r pharmacological agents in serum-free medium (Rozengurt. 1986 ). Studies performed using such growth-arrested cells and defined combinations of Abbreviations used: PKC. protein kinase C : VIP. vamintestinal growth factors have revealed the existence of potent and specific synergistic interactions involved in mitogenic stimulation (revicwcd in Rozengurt. 1986 ).
An important step in elucidating the basis o f growth factor action is t o identify the signal-transduction pathwayis) involved in the gcncration of thc mitogenic response. For years many investigators have proposed and searched for a single key signal governing the initiation o f cell proliferation. Extensive analysis of early signalling events, however, has led to the formulation of an alternative model: the existence of multiple growth-factor-activated signalling pathways that synergistically Icad to a mitogenic response (Rozengurt. 19x6 ; Rozengurt tv ul., I Y X X ) . In this paper we summarize some recent findings concerning the cyclic A M P signal-transduction pathway in thc mitogenic response of Swiss 3T3 cells.
C jclic A MI' (i I I (1 t t I i f oget i esis
A variety of agents that promote cyclic A M P accumulation in Swiss 3'13 cells, including prostaglandin E , ( P G E , ) , the adenosine agonist 5'-N-ethylcarboxamideadenosine (NECA). cholera toxin and permeable cyclic A M P analogues stimulate DNA synthesis by acting syncrgistically
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with insulin, phorbol esters and other factors (reviewed in Rwengurt, 1986) . Furthermore, the neuropeptide vasoactive intestinal peptidc (VIP) both promotes rapid accumulation of cyclic A M P and stimulates reinitiation of DNA synthesis in 3 T 3 cells whcn added in the presence of insulin and modulators o f cyclic A M P metabolism such as forskolin o r inhibitors of cyclic A M P phosphodiesterase (Zurier ('I trl., 1988) . Finally, platelet-derived growth factor (PDGF ), one of the most potent mitogens for fibroblasts. induccs a striking accumulation of cellular cyclic A M P mediated, at least in part, by increased synthesis of E-type prostaglandins, which in turn leave the cell and stimulate cyclic A M P synthesis through their own receptor (Rozengurt c't ul., 1983) . Together these findings indicate that a sustained increase in cellular cyclic A M P acts as a mitogenic signal for Swiss 3 T 3 cells. In the following sections we will consider some of the molecular mechanisms underlying the cyclic AMP-mediated mitogenic response. Rozengurt. 1988I . If these striking changes in intermediate filament distribution iri iivo are indeed caused by cyclic AMP-mediated phosphorylation of vimentin at specific sites, the phosphorylation profile of vementin obtained from intact cells incubated with "P and cyclic A MP-increasing agents should be comparable to that o f purified vimentin phosphorylated iri vitro by the catalytic subunit of cyclic AMP-dependent protein kinase. Fast protein liquid chromatography (f.p. 1.c.) analysis of tryptic peptides generated from such irr iiiw and iri iitro phosphorylated vimentin support this hypothesis. A s shown in Fig. I . three peaks were identified (designated I, II and 111) the phosphorylation of which was enhanced by the elevation of cyclic A M P iri tivo or by the addition of the catalytic subunit of cyclic AMP-dependent protein kinase iri vilro.
T h e question remains as t o how the cyclic A M P accumulation and subsequent vimentin phosphorylation induced by cyclic AMP-increasing agents might function to regulate the mitogenic response. One attractive model is that intact intermediate filaments transmit a negative signal which restricts the initiation o f the cell cycle in 3T3 cells. T h e dissociation and redistribution of these filaments induced via specific vimentin phosphorylation by cyclic AMP-dependent protein kinase might remove a constraint for the initiation of cell proliferation.
Irideperiderice of c;vcYic AMI' trritl other sigriul truristlrrc.tiori
T h e phosphorylation of the M,-S8 000 vimentin protein is useful as a rapid and specific indicator of the activation of the cyclic AMP-dependent signalling pathway in Swiss 3T3 cells.
ptrth wuy.5 It was important therefore to determine the effect of cyclic A M P on other phosphorylation substrates that serve as indicators o f the activation of other growth-factor-induced signalling pathways. It is known that a rapid increase in the phosphorylation of an acidic cellular protein with an M , of 80000 reflects the activation of protein kinase C (PKC) in intact and permeabilized 3T3 fibroblasts (Erusalimsky CI d., 1988) , and in cell-free systems (Rodriguez-Pena & Rozengurt. I Y86). Recent purification o f a phosphoprotein closely related t o the M,-80000 protein from rat brain has yielded an apparently homogeneous protein that is an effective substrate of PKC and contains an unusually high proportion of the acidic amino acids glutamine and asparab' m e , as well as alanine (Morris & Rozengurt. 1 Y88). Although thc nature and role of the M , -8 0 000 phosphoprotein remain to be elucidated. its phosphorylation provides a specific marker for assessing which mitogenic agents activate PKC in intact cells. T h e phosphorylation of the M , -8 0 000 protein was not increased either by the pharmacological agents used to increase cyclic A M P (Escribano & Rozcngurt, lY88) o r by the neuropeptide VIP (Zurier ('t trl., 1988) . Furthermore, down-regulation of PKC, which blocks the cellular response t o mitogens that act via the PKC signal-transduction pnthway. does not prevent mitogenesis in response t o growth factors or othcr agcnts that increase cyclic A M P levels (Collins & Rozengurt. lY84). These results indicate that the PKC and cyclic AMP-mediated signal-transduction pathways represent distinct and independent mechanisms for mitogenic stimulation. While it is known that several growth factors that elevate cyclic A M P levels also induce c-fi~s and c-myc, the specific role of cyclic A M P elevation in the induction of these protooncogenes has not been clearly defined. Recently Mehmet et ul. (1 988) found that 3T3 cells treated with forskolin exhibit a 20-fold lower level of c-fi).s mRNA than those stimulated with PKC-activating agents, though they show maximal c-riiyc expression. Furthermore. the combination of forskolin and insulin, which is mitogenic for 3T3 cells, also gave low levcls of c-fi~s mRNA. though c-rriy expression was again maximal. These rcsults show that ii large induction of c -J h mRNA is not necessary for cyclic AMP-mediated mitogenesis (Mehmet (it (11.. 1988) .
C 'ross-tulk hcvwecri I'KC' tirid c:\'clic A MI' .sigritiI path wq*.s
While. as shown above. cyclic A M P and PKC rcprcscnt separate signal-transduction pathways, recent results indicate the existence of interactions between these major transmembranc signalling systems. Specifically, activation of PKC by either phorbol esters or diacylglycerols markedly enhances the accumulation of cyclic A M P in response to forskolin or cholera toxin, while down-regulation of PKC blocks this enhancing effect (Rozengurt et ul., 1987) .
A further example of cyclic AMP/PKC signal pathway interactions has come from studies with the neuropeptidcs of the bombesin family. These peptides bind to specific receptors in Swiss 3T3 cells and stimulate inositol polyphosphate formation, mobilization of Ca" from intraccllular stores, activation of PKC. inhibition of epidermal growth 
. c. unulvsis oJ vimetititi rtypric peptides
It1 i i L v labelling o f vimentin: confluent, quiescent cultures o f Swiss 3T3 cells were labelled with '?P, (400 pCi/ml) for 4 h as previously described (Escribano & Rozcngurt, 1988) . Cultures were then treated with 25 p M-forskohn and 5 0 pM-3-isobutyl-I methylxanthine ( h ) or ethanol vehicle alone ( m ) for 10 min at 37 "C. All subsequent steps were carried out at 4 "C. Cells were collected in a homogenization buffer containing 5 0 mM-Tris/HCI ( p H 7.4), 5 mM-MgClz, 10 m~-2-mercaptoethanoI, 0.6 M-KCI and I % (v/v) Triton X-100, and homogenized with a Dounce ' A' pestle until cell lysis was complete. T h e cellular debris was pelleted by Centrifugation for 30 min at 17 000 g, and washed twice with homogenization buffer. The resulting Triton-insoluble pellet was resuspended in 8 M-urea, SO mM-Tris/HCI (pH 7.4) , 5 mM-MgCI? and 5 mM-dithiothreitol to the original volume, and extracted for 4 h. After removal of the insoluble residue by centrifugation (30 min at 76 000 g). an equal volume of buffer without urea was added t o the supernatant followed by centrifugation at 76 000 g for 45 min. T h e resulting supernatant was diluted with 6 volumes of absolute ethanol and incubated overnight at 3 "C. Crude vimentin was collected by centrifugation for 30 min at 2 0 0 0 0 g. T h e resulting vimentin preparation was dissolved in SDS sample buffer and gel-purified by one-dimensional SDS/polyacrylamide-gel electrophoresis as described (Escribano &L Rozengurt, I 988). T h e M,-S8 000 protein was visualized by autoradiography and excised. T h e gel fragment was soaked for 30 min in 0.05 Mammonium bicarbonate (pH 8.0 ) and the vimentin was eluted by shaking in a solution of 0.05 M-ammonium bicarbonate. 0.05'%) (w/v) SDS ( p H 8.0) for 4 h. T h e protein was precipitated with trichloroacetic acid (20%, w/v. final concentration). washed twice with ethanol/ether ( 1 : 1, by vol.) and air-dried. T h e purified vimentin was then digested with one-tenth weight of L-1 -tosylamido-2-phenylethyl chloromethyl ketone trypsin (Sigma) for 24 h at room temperature in the ammonium bicarbonate/SDS buffer. After freeze-drying, the resulting tryptic peptides were resuspended in 0. I% (v/vj tritluoroacetic acid (TFA) to a concentration of 0.01 7 pg/pl. A n aliquot (0.1 pcg = 6 pI) o f the suspension was then analysed by reverse-phase chromatography using a Pep RPC H R 5 / 5 column and complete f.p.1.c. system (Pharmacia). Elution was with ii gradient o f acetonitrile ( 1 0 -lOO%, v/v) in 0.1% (v/v) TFA delivered at I ml/min and ambient temperature; the gradient profile is indicated in the Figure. Fractions were collected at 0.5 min intervals and analysed by liquid scintillation chromatography. ( c j /ti iitro labelling of vimentin: crude vimentin was prepared from non-labelled cells as noted above, then phosphorylated by the catalytic subunit of cyclic AMP-dependent protein kinase in 5 0 0 pI total volume, exactly as described by Inagaki i't trl. ( 1988). T h e phosphorylatcd preparation was gel-purified, digested with trypsin, freeze-dried and subjected t o f.p.1.c. analysis as detailed above.
factor ( IiGF ) binding. secretion of the l:-type prostaglandins and induction o f thc cellulx oncogenes c-/i).s and c -m y ( Rozengurt. 1986 ; Rozcngurt 111 ill., 1988) . Bombesin caused ii marked enhancement of cyclic A M P accumulation (in the presence o f forskolin); this increase is partially diminished both b y down-regulation of PKC' and by the cyclo-oxygenase inhibitor intlomethacin ( Millar M Rorengurt. 1988 ). T h e inhibitory effects are additive in nature. suggesting the existence of two mechanisms by which bombesin can enhance cyclic AMP accumulation. These findings suggest that cyclic A M P could contribute to the signalling of growth factors that primarily act through the PKC pathway.
One of the most intriguing areas of PKC'/cyclic A M P 'cross-talk' involves the molecular basis for these pathway interactions. Further studies using phorbol esters and cyclic AMP-increasing agents have shown that this 'cross-talk' is VOl. 17 Table I 
. Early responses elicited by wrious mitogens in Swiss 373 cells
The original data can be obtained from references in the respective sections in the text and from recent reviews (Rozengurt, 1986; Rozengurt er al., 1988 , and unpublished data). forskolin.
abolished by treatment with pertussis toxin in a time-and dose-dependent fashion. Since pertussis toxin does not itself promote cyclic A M P accumulation in Swiss 3T3 cells (Rozengurt et al., 1987) , it is unlikely to act by removing a tonic inhibitory influence o n the adenylate cyclase via G,. A n attractive possibility is that a novel pertussis toxin substrate mediates the 'cross-talk' between the PKC and the cyclic A M P pathways.
C'otlchrsiotls
The results discussed here provide evidence for the existence of multiple signal-transduction pathways in mitogenesis. Specifically, cyclic A M P and PKC represent two separate signal-transduction pathways for mitogenic stimulation. In the presence of insulin, an increase in the cellular levcl of cyclic A M P (by multiple pharmacological agents, prostaglandins o r the neuropeptide VIP) leads to DNA synthesis without an early activation of PKC, Ca?+ mobilization or a large induction of c-fos (Table 1) . Reciprocally, direct activation of a PKC pathway by phorbol esters or diacylglycerols causes reinitiation of D N A synthesis without an early increase in cyclic AMP; simultaneous activation o f the PKC and cyclic A M P pathways stimulates DNA synthesis in the absence of insulin or any othcr ligand that occupies a tyrosine kinase receptor. T h e synergistic effect between PKC and cyclic A M P provides a clear example of the elicitation of mitogenesis by the integration of defined, independent intracellular signal-transduction pathways.
In addition to the cyclic A M P and PKC-mediated pathways discussed here, there is ample evidence for the existence of yet other signal-transduction mechanisms. For example, insulin, which acts synergistically with agents that utilize either PKC or cyclic A M P pathways, but does not itself activate PKC or elevate cyclic AMP, is envisaged to initiate yet another mitogenic pathway. Indeed, stimulation of D N A synthesis in 3T3 cells by insulin and E G F occurs without activation of either the PKC or cyclic A M P pathways. Since the receptors for both insulin and EGF possess tyrosine kinase activity, it is possible that specific tyrosine phosphorylations of key intracellular proteins are involved in the mitogenic signal pathway utilized by these ligands. In conclusion, the results presented here indicate that longterm mitogenesis can be stimulated through multiple signal-transduction pathways that act in a synergistic fashion for transducing environmental signals from the whole organism into the mitogenic response of a specific cell.
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